A technology that utilizes inorganic materials as drug delivery carriers to enable the selective and efficient delivery of bioactive substances, including small molecules and genes, to target sites.
Designed to Overcome Limitations
Beyond conventional drug delivery systems
Designed to structurally address recurring challenges in conventional drug delivery systems, including reduced stability, inconsistent delivery, and limited scalability. This enables consistent delivery performance and broad clinical applicability, regardless of the type of substance being delivered.
Organic-Inorganic Hybrid DDS
Stability, Control, and Scalability
A technology that utilizes inorganic materials as drug delivery carriers to enable the selective and efficient delivery of bioactive substances, including small molecules and genes, to target sites.
Designed to Overcome Limitations
Beyond conventional drug delivery systems
Designed to structurally address recurring challenges in conventional drug delivery systems, including reduced stability, inconsistent delivery, and limited scalability. This enables consistent delivery performance and broad clinical applicability, regardless of the type of substance being delivered.
A Platform Across Therapeutic Areas
One design, multiple applications
Designed to be disease- and drug-agnostic, this platform delivery technology is applied to both the broad-spectrum antiviral platform XAFTY® and the oncology platform Penetrium™, reflecting a unified design philosophy across diverse therapeutic areas.
A Platform Across Therapeutic Areas
One design, multiple applications
Designed to be disease- and drug-agnostic, this platform delivery technology is applied to both the broad-spectrum antiviral platform XAFTY® and the oncology platform Penetrium™, reflecting a unified design philosophy across diverse therapeutic areas.
CEO geunwoo jin Email contact@hyundaibio.com Tel1544-3194 | Fax053-756-4055
